Androgen hypersensitivity in prostate cancer: molecular perspectives on androgen deprivation therapy strategies.

Androgen deprivation therapy is initially successful in treating advanced prostate cancer. However, after a period of time tumors inevitably recur. Improved understanding of the various biochemical causes of resistance to hormonal therapy is of crucial importance for developing more effective therapeutic strategies in this cohort of patients. This review… CONTINUE READING